Table of Contents

Select this article
- R P Robertson,
- L K Olson,
- and H J Zhang
Differentiating glucose toxicity from glucose desensitization: a new message from the insulin gene.
Diabetes September 1994 43:1085-1089; doi:10.2337/diabetes.43.9.1085
- Abstract
Select this article
- T J Lyons,
- W Li,
- M C Wells-Knecht,
- and R Jokl
Toxicity of mildly modified low-density lipoproteins to cultured retinal capillary endothelial cells and pericytes.
Diabetes September 1994 43:1090-1095; doi:10.2337/diabetes.43.9.1090
- Abstract
Select this article
- P Roach,
- Y Zick,
- P Formisano,
- D Accili,
- S I Taylor,
- and P Gorden
A novel human insulin receptor gene mutation uniquely inhibits insulin binding without impairing posttranslational processing.
Diabetes September 1994 43:1096-1102; doi:10.2337/diabetes.43.9.1096
- Abstract
Select this article
- J A Kim,
- J A Berliner,
- R D Natarajan,
- and J L Nadler
Evidence that glucose increases monocyte binding to human aortic endothelial cells.
Diabetes September 1994 43:1103-1107; doi:10.2337/diabetes.43.9.1103
- Abstract
Select this article
- F S Nielsen,
- P Rossing,
- M A Gall,
- P Skøtt,
- U M Smidt,
- and H H Parving
Impact of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy.
Diabetes September 1994 43:1108-1113; doi:10.2337/diabetes.43.9.1108
- Abstract
Select this article
- M F Saad,
- R L Anderson,
- A Laws,
- R M Watanabe,
- W W Kades,
- Y D Chen,
- R E Sands,
- D Pei,
- P J Savage,
- and R N Bergman
A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Insulin Resistance Atherosclerosis Study.
Diabetes September 1994 43:1114-1121; doi:10.2337/diabetes.43.9.1114
- Abstract
Select this article
- P Xia,
- T Inoguchi,
- T S Kern,
- R L Engerman,
- P J Oates,
- and G L King
Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia.
Diabetes September 1994 43:1122-1129; doi:10.2337/diabetes.43.9.1122
- Abstract
Select this article
- C A Conover,
- J T Clarkson,
- and L K Bale
Physiological concentrations of insulin induce cellular desensitization to the mitogenic effects of insulin-like growth factor I.
Diabetes September 1994 43:1130-1137; doi:10.2337/diabetes.43.9.1130
- Abstract
Select this article
- Y Liang,
- T L Jetton,
- E C Zimmerman,
- H Najafi,
- D K Berner,
- F M Matschinsky,
- and M A Magnuson
Effects of glucose on insulin secretion, glucokinase activity, and transgene expression in transgenic mouse islets containing an upstream glucokinase promoter-human growth hormone fusion gene.
Diabetes September 1994 43:1138-1145; doi:10.2337/diabetes.43.9.1138
- Abstract
Select this article
- M M Zanone,
- J S Petersen,
- M Peakman,
- C J Mathias,
- P J Watkins,
- T Dyrberg,
- and D Vergani
High prevalence of autoantibodies to glutamic acid decarboxylase in long-standing IDDM is not a marker of symptomatic autonomic neuropathy.
Diabetes September 1994 43:1146-1151; doi:10.2337/diabetes.43.9.1146
- Abstract
Select this article
- K J Wells-Knecht,
- T J Lyons,
- D R McCance,
- S R Thorpe,
- M S Feather,
- and J W Baynes
3-Deoxyfructose concentrations are increased in human plasma and urine in diabetes.
Diabetes September 1994 43:1152-1156; doi:10.2337/diabetes.43.9.1152
- Abstract
Select this article
- P M Piatti,
- A E Pontiroli,
- A Caumo,
- G Santambrogio,
- L D Monti,
- S Costa,
- F Garbetta,
- L Baruffaldi,
- C Cobelli,
- and G Pozza
Hyperinsulinemia decreases second-phase but not first-phase arginine-induced insulin release in humans.
Diabetes September 1994 43:1157-1163; doi:10.2337/diabetes.43.9.1157
- Abstract
Select this article
- T Otonkoski,
- M I Mally,
- and A Hayek
Opposite effects of beta-cell differentiation and growth on reg expression in human fetal pancreatic cells.
Diabetes September 1994 43:1164-1166; doi:10.2337/diabetes.43.9.1164
- Abstract
Select this article
- D W Scharp,
- C J Swanson,
- B J Olack,
- P P Latta,
- O D Hegre,
- E J Doherty,
- F T Gentile,
- K S Flavin,
- M F Ansara,
- and P E Lacy
Protection of encapsulated human islets implanted without immunosuppression in patients with type I or type II diabetes and in nondiabetic control subjects.
Diabetes September 1994 43:1167-1170; doi:10.2337/diabetes.43.9.1167
- Abstract

Diabetes

Differentiating glucose toxicity from glucose desensitization: a new message from the insulin gene.

Toxicity of mildly modified low-density lipoproteins to cultured retinal capillary endothelial cells and pericytes.

A novel human insulin receptor gene mutation uniquely inhibits insulin binding without impairing posttranslational processing.

Evidence that glucose increases monocyte binding to human aortic endothelial cells.

Impact of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy.

A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Insulin Resistance Atherosclerosis Study.

Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia.

Physiological concentrations of insulin induce cellular desensitization to the mitogenic effects of insulin-like growth factor I.

Effects of glucose on insulin secretion, glucokinase activity, and transgene expression in transgenic mouse islets containing an upstream glucokinase promoter-human growth hormone fusion gene.

High prevalence of autoantibodies to glutamic acid decarboxylase in long-standing IDDM is not a marker of symptomatic autonomic neuropathy.

3-Deoxyfructose concentrations are increased in human plasma and urine in diabetes.

Hyperinsulinemia decreases second-phase but not first-phase arginine-induced insulin release in humans.

Opposite effects of beta-cell differentiation and growth on reg expression in human fetal pancreatic cells.

Protection of encapsulated human islets implanted without immunosuppression in patients with type I or type II diabetes and in nondiabetic control subjects.

This Issue

Current Issue